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Summary
Altered epididymal sperm count and morphology following leptin treatment
has been reported recently. This study examined the effects of 42 days of leptin
treatment on sperm count and morphology and their reversibility during a
subsequent 56-day recovery period. Twelve-week-old male Sprague-Dawley rats
were randomised into four leptin and four saline-treated control groups
(n = 6). Intraperitoneal injections of leptin were given daily (60 lg Kg1 body
weight) for 42 days. Controls received 0.1 ml of 0.9% saline. Leptin-treated
animals and their respective age-matched controls were euthanised on either
day 1, 21, 42 or 56 of recovery for collection of epididymal spermatozoa.
Sperm concentration was determined using a Makler counting chamber. Sper-
matozoa were analysed for 8-hydroxy-2-deoxyguanosine and DNA fragmenta-
tion (Comet assay). Data were analysed using ANOVA. Sperm concentration was
significantly lower but fraction of abnormal spermatozoa, and levels of
8-hydroxy-2-deoxyguanosine were significantly higher in leptin-treated rats on
day 1 of recovery. Comet assays revealed significant DNA fragmentation in
leptin-treated rats. These differences were reduced by day 56 of recovery. It
appears that 42 days of leptin treatment to Sprague-Dawley rats has significant
adverse effects on sperm count and morphology that reverse following
discontinuation of leptin treatment.
Introduction
Leptin has been shown to have roles in numerous physio-
logical processes including regulation of body weight,
food intake, cardiovascular function, immune function,
hematopoiesis, inflammation, sexual maturation and nor-
mal reproduction (Fantuzzi & Faggioni, 2000; Haluzik
et al., 2000; Mantzoros, 2000; Waelput et al., 2006;
Sayed-Ahmed et al., 2012). With regard to reproduction,
treatment of infertile ob/ob mice with leptin restores their
reproductive ability (Barash et al., 1996; Mounzih et al.,
1997). Leptin receptor isoforms have been reported in
gonadal tissue, suggesting a direct endocrine action of
leptin on the gonads (Zamorano et al., 1997; El-Hefnawy
et al., 2000). The precise role of leptin in the testes has
not been fully established and remains a focus of current
studies. The presence of leptin receptors in Leydig and
Sertoli cells suggests that it might have a role in the
endocrine function of the testes and in spermatogenesis.
Interestingly, leptin is secreted by human ejaculated
spermatozoa, and the secretion is significantly higher in
spermatozoa incubated in capacitating conditions (Aquila
et al., 2005). Leptin together with insulin has also been
shown to enhance human sperm motility (Lampiao & du
Plessis, 2008).
Whilst the role of leptin in normal reproductive
function is now increasingly recognised, leptin adminis-
tration to normal adult non-obese rats, has been found to
adversely affect sperm count and sperm morphology
(Haron et al., 2010, 2013; Abbasihormozi et al., 2013).
Whilst the link between obesity related infertility and
leptin remains to be established; however, it remains
unknown if the reported effects of exogenous leptin
administration on sperm count and morphology are
reversible upon discontinuation of leptin treatment.
Besides, the duration required for recovery is also not
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known. This study therefore examined the effect of 21, 42
and 56-day recovery period following 42 days of leptin
treatment on sperm count and morphology in normal
adult rats. In addition, it also examined evidence for
DNA damage following leptin treatment and recovery.
Materials and methods
Twelve-week-old male Sprague-Dawley rats were rando-
mised into four leptin-treated and four saline-treated,
age-matched control groups with six rats per group.
Intraperitoneal injections of leptin at a dose of
60 lg kg1 body weight in 0.1 ml 0.9% saline were given
daily for 42 days (recombinant rat leptin, purity >95%;
Biovision, San Francisco, USA). Controls received 0.1 ml
of 0.9% saline over the same period. The duration and
dose of leptin treatment were based on our previous
studies in the rat where we found that a more pro-
nounced effect of leptin was evident following 42 days of
treatment than after 7 or 21 days of treatment (Haron
et al., 2010, 2013). Although the dose of leptin used in
these studies ranged from 5–30 lg Kg1, but to ensure a
more pronounced effect, a dose of 60 lg Kg1 was used
in this study. On day 43, that is 1 day after the comple-
tion of leptin treatment, one group of leptin-treated rats
together with an age-matched saline-treated control group
was euthanised for collection of epididymal spermatozoa.
This provided the sperm data for day 1 of the recovery
period. The remaining three groups, together with their
age-matched saline-treated controls, were allowed to
recover further and then euthanised at either days 21, 42
or 56. Euthanisation was carried out using a small animal
guillotine. The duration of the recovery period was
approximated to the 54-day sperm cycle in the rat. Days
21 and 42 were chosen arbitrarily as representing 35–40
and 70–75%, respectively the length of the sperm cycle.
The study design was approved by the Animal Care and
Users Committee, Universiti Teknologi MARA.
Sperm collection
Immediately following euthanisation, a laparotomy was
performed, and the left epididymis was removed and
weighed. The cauda of each epididymis was cut and
minced separately in 2 ml of normal saline and filtered
through nylon mesh for collection of spermatozoa
(Haron et al., 2010). An aliquot of the epididymal sus-
pension was then used for sperm count and morphology
using a Makler counting chamber (Sefi Medical Instru-
ments LTD, Haifa, Israel). The remainder was used for
sperm DNA damage detection and estimation using
comet assay and sperm DNA damage marker 8-hydroxy-
2-deoxyguanosine (8-OHdG) respectively.
Sperm concentration and morphology
The sperm specimen was mixed thoroughly, and a small
drop was then pipetted onto the centre of the disc area of
a Makler chamber. The number of spermatozoa in a strip
of 10 squares was counted. This number represented the
concentration in million per ml. This was repeated on
another strip, and the average of the two counts was
recorded. The number of abnormal spermatozoa in the
same strip of 10 squares was counted and recorded.
Spermatozoa were classified into normal and abnormal
types as described previously (Narayana et al., 2002). In
brief, the spermatozoa with the following characteristics
were considered abnormal: (i) headless, (ii) hookless, (iii)
cephalo-cauda, (iv) double headed, (v) broken tail, (vi)
microcephalic, (vii) coiled tail, (viii) double tailed.
Quantitative measurement of 8-hydroxy-2-
deoxyguanosine (8-OHdG)
Genomic DNA was isolated from spermatozoa sample of
each animal using Genomic DNA Isolation Kit (Biovision
USA). The isolated DNA was first hydrolysed into nucleo-
tides by incubating it with 100 U ml1 nuclease P1
(Sigma-Aldrich, St Louis, USA) in 20 mM sodium acetate
buffer (pH 4.5) at 37 °C for 60 min. Following this, one
unit of alkaline phosphatase (Sigma-Aldrich) was added
per 100 lg of DNA and incubated at 37 °C for another
30 min. After incubation, the DNA lysate was boiled for
10 min and then placed on ice until measurement. The
level of 8-OHdG was estimated using 8-hydroxy-2-deoxy
Guanosine EIA Kit (Cayman Chemical, Michigan, USA).
Detection of sperm DNA damage using comet assay
Sperm DNA damage was assessed using the single cell
gel/comet assay according to Tripathi & Jena (2008).
Fully frosted slides were covered with 100 ll of 1% nor-
mal melting agarose (NMA), and with a cover slip in
place, the agarose was allowed to solidify at 4 °C for
5 min. An agarose sperm suspension was prepared by
mixing 10 ll of fresh sperm suspension containing
1 9 105 spermatozoa with 90 ll of 1% low melting
agarose (LMA).
After removal of the cover slip from the frosted slides,
85 ll of the sperm suspension in 1% LMA was pipetted
onto the slides to form the second layer. A fresh cover
slip was placed, and the agarose was allowed to set at
4 °C for 10 min. The cover slips were then removed, and
the slides were placed in jars containing lysis buffer
(2.5 M NaCl, 100 mM Na2 EDTA, 10 mM Tris containing
1% Triton X-100, 40 mM DL- dithiothreitol and protein-
ase K 0.5 mg/ml) at 37 °C for 24 h. Following lyses, all
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slides were washed three times with deionised water at
10 min interval to remove salt and detergent from the
gels. Slides were then coded and placed in a horizontal
electrophoresis tank (Model Sub-Cell GT Basic, BIO-RAD,
Hercules, CA, USA, Max. volts 1000 V, Max. current
500 mA) filled with fresh alkaline electrophoresis buffer
(300 mM NaOH and 1 mM EDTA pH 13) for 20 min to
allow the DNA from the cells to unwind. Electrophoresis
was performed at room temperature and conducted at
25 V, 300 mA for 20 min. The slides were then washed
and neutralised using neutralisation buffer (0.4 M Tris-
Base, pH 7.5) in three different jars with the duration of
wash at 5 min per jar. After neutralisation, the slides were
dried and stained with DNA SYBR Green 1 (1 : 10 000
dilution) for 30 min. The slides were then rinsed quickly
with double-distilled water, and cover slips were placed for
image analysis. The fluorescent labelled DNA was
visualised (2009) using a BX 61 Imager fluorescence
microscope (Olympus Co., Tokyo, Japan), and the result-
ing images were captured on a computer. The analyses of
comet images were performed by the automated software
Comet Assay Software Project lab V.1.2.3b1 (CASP, Sour-
ceforge, Diceholdings Inc, NY, USA). Samples were run in
duplicate, and 100 cells were randomly analysed per slide
for a total of 200 cells per sample and scored for tail length
(TL), tail moment (TM), olive tail moment (OTM) and %
tail DNA (% DNA).
Statistical analysis
Data were analysed using one-way analysis of variance
(ANOVA) for multiple comparisons followed by post hoc
Tukey’s analysis contained in the SPSS version 20, IBM,
NY, USA and expressed as mean  SEM. Statistical sig-
nificance was accepted at P < 0.05. No animals were lost
during the study, and data from all the rats are included
in the analysis.
Results
Body weight increased significantly over the duration
of the study in both groups (P < 0.001), but there were
no significant differences in body weight between
leptin-treated rats and their age-matched controls either
during leptin treatment or during the recovery period
(Table 1).
Mean sperm count at days 1, 21 and 42 of recovery
was significantly lower in leptin-treated rats when com-
pared to that in age-matched controls (P < 0.001, 0.001
and 0.05, respectively; Fig. 1). Total sperm count
increased during recovery, and no significant difference
was evident in sperm count between leptin-treated rats
and their respective age-matched controls on day 56 of
recovery.
The fraction of spermatozoa with abnormal morphol-
ogy at days 1, 21 and 42 of recovery was also significantly
higher in leptin-treated rats when compared to that in
the controls (P < 0.001, 0.001 and 0.01, respectively;
Fig. 2). Headless and coiled-tail spermatozoa were the
two most common types of abnormal sperm seen. The
fraction of spermatozoa with abnormal morphology,
however, declined with increasing duration of recovery,
where, by day 56 of recovery no significant difference was
evident between the two groups.
Sperm 8-OHdG levels were significantly higher imme-
diately after completion of 42 days of leptin treatment,
that is at recovery day 1 (Fig. 3). Its concentration, how-
ever, declined over the recovery period, and the difference
was no longer significant from that in non-treated age-
matched controls at day 56 of recovery.
Compared to the controls, comet assay revealed signifi-
cantly higher tail length, tail moment, olive tail moment
and % tail DNA in leptin-treated rats both immediately
after the completion of leptin treatment (i.e. recovery day
1) and at recovery days 21, 42 and 56 (Table 2; Fig. 4).
There was, however, a general tendency for all these
parameters to shift towards the control values with
increasing duration of recovery.
Discussion
The major findings of this study include (i) a signifi-
cantly lower sperm count following leptin treatment that
returned to levels similar to those in the controls by day
56 following the discontinuation of leptin treatment,
(ii) significantly higher fraction of spermatozoa with
Table 1 Body weight in control and leptin-treated rats
Day 1 21 42 56
Leptin treated Leptin treatment Recovery period
413.6  6.4 (n = 6) 418.5  5.4 (n = 6) 464.8  4.6### (n = 6) 525.3  2.75### (n = 6)
Control saline Saline treatment Recovery period
412.6  6.32 (n = 6) 419.7  3.86 (n = 6) 489.2  7.07### (n = 6) 514.0  1.99###(n = 6)
###P < 0.001 compared to their respective weight at day 0 (i.e. day 43 or one day after the completion of leptin treatment).
© 2014 Blackwell Verlag GmbH 3
Andrologia 2014, xx, 1–8
F.A. Almabhouh et al. Effects of leptin on spermatozoa are reversible
abnormal morphology following leptin treatment, which
recovered to levels similar to those in the controls by
day 56 of recovery, (iii) significantly higher DNA frag-
mentation that did not completely recover by day 56
following the discontinuation of leptin treatment, and
(iv) increased levels of 8-hydroxy-2-deoxyguanosine (8-
OHdG) levels following leptin treatment that returned
to levels similar to those in the controls by day 56 of
recovery.
Decreases in sperm count and increased fraction of
spermatozoa with abnormal morphology following leptin
treatment in the rat have been reported before (Haron
et al., 2010, 2013; Abbasihormozi et al., 2013). Increased
serum FSH and LH levels following leptin administration
were also reported in these studies. Although leptin has
been shown to influence the release of gonadotrophin-
releasing hormone (Quennell et al., 2009), it is unlikely
that the lower sperm count and the increased fraction of
morphologically abnormal spermatozoa following leptin
treatment were due to the effect of leptin on the pitui-
tary-gonadal axis. Serum testosterone levels were not
significantly altered following leptin treatment (Haron
et al., 2010). A direct effect of leptin on the testes and on
spermatogenesis, perhaps involving oxidative stress, there-
fore appears more likely. In this regard, increased produc-
tion of reactive oxygen species (ROS) and markers of
oxidative stress in the testes following leptin treatment
have been reported recently (Abbasihormozi et al., 2013).
In addition, leptin has also been shown to cause perox-
ynitrite-mediated oxidative stress in steatohepatic lesions
(Chatterjee et al., 2013) and correlate negatively with
paraoxonase activity in venous blood of obese pregnant
women (Ferretti et al., 2013). Moreover, a negative corre-
lation between ROS levels and semen quality has also
been reported (Gomez et al., 1998; Agarwal et al., 2003,
2005; Makker et al., 2009). Although low levels of ROS
activity are considered necessary for normal sperm func-
tion, higher levels could be detrimental and could
increase DNA fragmentation and apoptosis in the sper-
matozoa and the seminiferous tubules. Comet assay
analysis revealed evidence of significant DNA fragmenta-
tion following leptin treatment, which decreased with
increasing duration of recovery (Table 2; Fig. 4). In
addition, sperm 8-OHdG, a useful marker for the
assessment of the impact of oxidative stress on DNA, was
significantly higher in leptin-treated rats, particularly
immediately after the 42-day treatment (Fig. 3). The
















Fig. 1 Sperm morphology in controls and leptin-treated rats during

























Fig. 2 Sperm count in leptin-treated and control rats during the



















Fig. 3 Sperm 8-hydroxy-2-deoxyguanosine (8-OHdG) levels in
leptin-treated rats during recovery and their age-matched controls.
*P < 0.05, **P < 0.01; ***P < 0.001.
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stress following leptin treatment, however, remains
unclear. DNA fragmentation can arise from numerous
intrinsic and extrinsic factors. As sperm collection,
storage and handling techniques were the same in both
the control and leptin-treated groups in this study, it
would therefore be reasonable to assume that the differ-
ences in the levels of DNA fragmentation evident in this
study are probably due to intrinsic causes secondary to
leptin treatment. Whilst the increased levels of 8-OHdG
in leptin-treated rats suggest a role for oxidative stress in
the DNA fragmentation, there is still a need to ascertain
whether the mechanism of the increased fragmentation
involves other sources as well. It could result from defi-
ciencies in recombination during spermatogenesis, abnor-
Table 2 Comet assay summary sheet during the recovery periods
Groups Tail length (n = 6) Tail moment (n = 6) Olive tail moment (n = 6) %Tail DNA (n = 6)
Control 19.25  2.9 2.09  0.43 2.25  0.56 0.88  0.09
Leptin (Recovery day 1) 39.87  0.9*** 7.19  0.3*** 6.56  0.14*** 1.61  0.07***
Leptin (Recovery day 21) 35.57  1.08*** 6.01  0.27*** 6.14  0.2*** 1.37  0.1***
Leptin (Recovery day 42) 34.59  1.7*** 5.9  0.51*** 5.69  0.34*** 1.29  0.13**
Leptin (Recovery day 56) 27.55  1.56** 4.09  0.37** 4.61  0.31** 1.19  0.11*










Fig. 4 Photomicrographs showing DNA
migration pattern of sperm nuclei in single
cell gel electrophoresis (comet assay) stained
with SYBR Green-I during recovery.
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mal spermatid maturation or even variations in sperm
protamine expression during spermiogenesis. It is known
that during spermiogenesis, 85–95% of histones in the
DNA are replaced by protamines 1 and 2 (P1, P2) result-
ing in compaction of the nucleus and cessation of gene
expression (Conwell et al., 2003; Oliva, 2006; Barratt
et al., 2010). Altered P1/P2 ratios have been associated
with increased DNA fragmentation (Garcia-Peiro et al.,
2011; Simon et al., 2011). The impact of leptin on
spermatogenesis has not been reported before, and it is
possible that leptin either directly or through increased
oxidative stress might be influencing it, resulting in
increased DNA fragmentation. The pattern of changes in
DNA fragmentation and sperm 8-OHdG levels seems to
suggest the involvement of oxidative stress (Fig. 3). Stud-
ies involving the use of anti-oxidants could help identify
the role of oxidative stress in leptin-induced increased
DNA fragmentation. Preliminary studies in our labora-
tory using anti-oxidants seem to implicate the role of
oxidants in leptin-induced changes in sperm count and
morphology (FA Almabhouh, HJ Singh, unpublished
data).
The finding of adverse effects of leptin on spermatozoa
might have relevance in obesity related infertility in
males. The prevalence of infertility, for example, is
reportedly high in obese males (Nguyen et al., 2007). In
addition, a recently published review of 23 studies on
sperm function found 15 of these studies reporting a
lower sperm concentration in obese males (Palmer et al.,
2012). Serum leptin concentrations are positively corre-
lated with total body fat mass (Shimizu et al., 1997), and
it is possible the high levels of leptin might be responsible
for the lower sperm concentration in obese males.
The fraction of spermatozoa with abnormal morphol-
ogy seems to increase slightly with age in controls
(Fig. 2). Age-related decrease in sperm quality has been
reported before, but the precise reason for this remains
unclear although it has been attributed to age-related
degeneration or senescence in the seminiferous tubules,
seminal vesicle and the prostate (Kidd et al., 2001; Esken-
azi et al., 2003). Body weight was not different between
the controls and leptin-treated groups during leptin treat-
ment or during recovery (Table 1). The lack of effect on
body weight following leptin treatment could be due to
the dose used and to the fact that it was given as a single
daily dose. Given its short half-life of 9–12 min (Zeng
et al., 1997) it might be argued that its effects on appetite
might only be transient, and a rebound feeding could
prevent any changes in body weight. Suppression of food
intake for a short duration is often also associated with a
rebound increase in food intake for a short while after-
wards (Kumar et al., 2002). Of more importance in this
study is that the effects of leptin on spermatozoa were
evident without significant differences in the changes in
body weight.
Whilst the effect of leptin on sperm morphology and
count has been reported before, to date no reports exist
as to whether these effects are reversible following
cessation of leptin treatment. Data from this study
suggest that discontinuation of leptin after 42 days of
treatment at a dose of 60 lg kg1 requires an approxi-
mate duration of at least 56 days or more for recovery
from leptin-induced changes in sperm count and mor-
phology (Figs 1 and 2).
The requirement of up to 56 days or more for a signifi-
cant recovery from the adverse effects of leptin seems to
suggest that the adverse effects of leptin might include its
affects on processes further upstream in spermatogenesis.
The further upstream the effect, the longer will be the
duration required for complete recovery. The upstream
effect could involve the early phases of spermatogenesis.
Spermatogenesis can be described to occur in three phases.
The first is where the spermatogonia undergo a series of
mitotic amplifying divisions and differentiate into sperma-
tocytes. The second phase is where the spermatocytes
undergo meitotic recombination giving rise to haploid
spermatids. The third, termed spermiogenesis involves
transformation into mature spermatozoa involving chro-
matic remodelling and replacement of histones with transi-
tion proteins first and then with protamines. Leptin, it
seems, could influence any one or all of these processes.
Clearly, more studies are needed to investigate this.
In conclusion, it appears that exogenous leptin admin-
istration adversely affects sperm count and morphology.
It also significantly increases DNA fragmentation and the
DNA marker of oxidative stress. These effects are revers-
ible following the discontinuation of leptin treatment and
require about 8 weeks.
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